AI-generated analysis. Always verify with the original filing.
iBio, Inc. entered into a new Open Market Sale Agreement (ATM Agreement) with Jefferies LLC on February 27, 2026, for at-the-market offerings of up to $100,000,000 of common stock under a new S-3 registration statement. The company terminated its prior ATM Agreement with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC on February 23, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry Into a Material Definitive Agreement. On February 27, 2026, iBio, Inc., a Delaware corporation (the “Company”), entered into an Open Market Sale Agreeme
. Termination of a Material Definitive Agreement. On February 23, 2026, the Company provided notice terminating the At Market Issuance Sales Agreement (the “Pri
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 1.1 Open Market Sale Agreement SM , dated February 27, 2026, by and betwee
Material Agreement